Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
 
  USER NAME  
  PASSWORD  
   Or select

Or become a subscriber
 
 
 

The Green Chemistry Approach to Pharma Manufacturing

Michael Kopach at Eli Lilly & Co, David Leahy at Bristol-Myers Squibb and Julie Manley at the ACS Green Chemistry Institute discuss corporate sustainability, greener metrics and technologies – and how these affect a company’s bottom line.

Michael Kopach, Eli Lilly & Co, David Leahy, Bristol-Myers Squibb and Julie Manley, the ACS Green Chemistry Institute (December 2012)

Keywords: Green technologies Continuous processing Solvent waste Process mass intensity (PMI) E-Factor

    View full article    |    Back to Manufacturing section




Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |